Daftar Login

MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated

MEREK : mbs303

MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated

mbs303MBS303 * Melestarikan Hutan Indonesia untuk Masa Depan yang Lebih Hijau. IDR 10,000.00. MBS303 menekankan pentingnya menggunakan media sosial secara positif.MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. The

IDR 10.000
IDR 100.000 Disc -90%
Kuantitas